Ivermectin shows clinical benefits in mild to moderate COVID19: A randomised controlled double blind dose response study in Lagos

Olufemi Emmanuel Babalola; Christopher Olusanjo Bode; Adesuyi Adeyinka Ajayi; Felix M Alakaloko; Iorhen Ephraim Akase; Erere Otrofanowei; Olumuyiwa Babalola Salu; Wasiu Lanre Adeyemo; Adesoji O Ademuyiwa; Sunday A Omilabu

bioRxiv (2021) - Comments
doi: 10.1101/2021.01.05.21249131

Olufemi Emmanuel Babalola, Christopher Olusanjo Bode, Adesuyi Adeyinka Ajayi, Felix M Alakaloko, Iorhen Ephraim Akase, Erere Otrofanowei, Olumuyiwa Babalola Salu, Wasiu Lanre Adeyemo, Adesoji O Ademuyiwa, Sunday A Omilabu